Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Life as a Flight Attendant During COVID-19: I Don’t Care

This week on I Don’t Care, Kevin Stevenson invited a very special guest on to the show to discuss the impact of the COVID-19 crisis on the airline industry. Kevin’s wife, Michelle, is a flight attendant for a major airline and gave some insight into the enhanced cleaning protocols, crew safety and changes in…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

This week on I Don’t Care, Kevin Stevenson invited a very special guest on to the show to discuss the impact of the COVID-19 crisis on the airline industry. Kevin’s wife, Michelle, is a flight attendant for a major airline and gave some insight into the enhanced cleaning protocols, crew safety and changes in air travel in light of the current health crisis facing most of the world.

On another MarketScale podcast, Roads, Rails, & Rides, Jeb Morris brought up a staggering number in the reduction of travel in North America right now. TSA has reported as having gone from 2 million passengers a day going through security last March to roughly an average of 200,000 people going through security. With a 90% drop off in air travel many pilots, flight attendants, and passengers have reported being on a flight with fewer than 10 passenger onboard. Even with the steep drop off in business it is more cost effective to keep the planes in the air going to their next destination than it is to cancel some routes and bringing new planes to cover the active routes.

Michelle Stevenson discusses how her employer has increased the frequency of deep cleaning the aircraft from at the end of each day to even in between flights. Despite the drop in the usage of each seat, airlines are more focused than ever to make sure to disinfect all surfaces that would be susceptible to transmission of the virus.

Airlines across the industry are reconciling with the uncertain future of air travel by determining when furloughs are necessary and how to keep as many employees as possible active. To accommodate the reduction in active routes, some airlines are allowing crew members to have the option of extended time off to reduce the strain of active employees.

If you are interested in reading statements from airlines about how they are handling the COVID crisis we have linked the statements from the major airlines below.

Catch upon previous episodes of I Don’t Care with Kevin Stevenson!

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512